Business Wire

Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.

Results: 11761-11772 of 13725

“The NEUROFUSE Study has yielded promising early clinical results consistent with preclinical studies of NTX-001,” said Evan Tzanis, Chief Operating Officer and EVP of R&D at Neuraptive Therapeutics, Inc. (Photo: Business Wire)

Neuraptive Therapeutics, Inc. Announces Achievement of Proof of Concept in The NEUROFUSE Study of NTX-001 for the Adjunct Treatment of Transected Peripheral Nerves

Ubiquiti Inc. Introduces UniFi 7, A Massively Scalable Wi-Fi 7 Solution That Revolutionizes Wireless Connectivity

KBRA Releases Research – European Securitisation: A Resurgent Market

Home Connectivity Alliance Announces HCA Energy Management Interface Specification 1.0 at CES 2024

VeriSilicon Unveils the New VC9800 IP for Next Generation Data Centers

Morgan Stanley Expansion Capital Leads $34M Series C Investment in Vortexa (Graphic: Business Wire)

Morgan Stanley Expansion Capital Leads $34M Series C Investment in Vortexa

Validant Group of Companies Unite as ELIQUENT Life Sciences

SurveyMonkey Reveals New Business, Cultural, and Social Trends in Second Annual State of Surveys Report

Announcing the Financial Narrative 50!

ZOLL Receives FDA Clearance and CE Mark to Expand the Thermogard Platform – All-In-One Core and Surface Cooling

Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs

LivaNova to Wind Down Advanced Circulatory Support Business Unit